Skip to main content
ANEB logo

ANEB · Anebulo Pharmaceuticals, Inc. · Shareholders & Ownership

Track ANEB — free
$0.43 +0.07 (+20.56%) At close · Mar 2
Market Cap
$13.46M
Shares
40.78M
Volume · Mar 2 21.4K Avg daily vol (3M) 99.57K

Every disclosed holder of ANEB in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns ANEB

13F quarter Dec 31, 2025

No chart: the summed disclosures exceed shares outstanding, so they are not parts of one whole.

Holder group Shares % Out
Institutional (13F) 22,208,816 54.45%
Insiders (Forms 3, 4, 5) 20,121,828 49.34%
13D/G-only blocks 0 0.00%
Remaining 1,545,913 -3.79%
Registered funds (N-PORT, not summed) 0 0.00%

Shares outstanding: 40,784,731, the issuer's latest cover-page count restated onto today's split basis.

Remaining is negative: the summed disclosures exceed shares outstanding, as when filings are dated at different times or holders that do not disclose their links count the same shares. It is flagged, not clipped.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of ANEB

# Holder Shares
1
Aron R. English
13D CIK 1770436 · Unknown · Feb 24, 2025
Item 4 purpose: not restated by this amendment, the earlier 13D's purpose stands
not summed
21,929,880
1.1
English Aron R.
Insider CIK 1770436 · Dec 23, 2024
10% Owner, issuer-wide
20,121,828
2
22NW, LP
13F CIK 1694297 · Registered investment adviser · Dec 31, 2025
15,467,300
3
Nantahala Capital Management, LLC
13F CIK 1472322 · Registered investment adviser · Dec 31, 2025
3,036,325
3.1
Nantahala Capital Management, LLC
13G CIK 1472322 · Registered investment adviser · Dec 31, 2025
Rule 13d-1(b), qualified institution, not summed
3,547,398
4
MANGROVE PARTNERS IM, LLC
13F CIK 1535392 · Registered investment adviser · Dec 31, 2025
2,525,252
5
VANGUARD GROUP INC
13F CIK 102909 · Registered investment adviser · Dec 31, 2025
435,821
6
MORGAN STANLEY
13F CIK 895421 · Holding company · Dec 31, 2025
399,404
7
GEODE CAPITAL MANAGEMENT, LLC
13F CIK 1214717 · Registered investment adviser · Dec 31, 2025
160,760
8
Rangeley Capital, LLC
13F CIK 1517796 · Registered investment adviser · Dec 31, 2025
50,000
9
RENAISSANCE TECHNOLOGIES LLC
13F CIK 1037389 · Registered investment adviser · Dec 31, 2025
25,098
10
CITADEL ADVISORS LLC
13F CIK 1423053 · Registered investment adviser · Dec 31, 2025
24,239
11
BlackRock, Inc.
13F CIK 2012383 · Holding company · Dec 31, 2025
23,790
12
NORTHERN TRUST CORP
13F CIK 73124 · Bank · Dec 31, 2025
21,994
13
Ikarian Capital, LLC
13F CIK 1778253 · Registered investment adviser · Dec 31, 2025
17,736
14
STATE STREET CORP
13F CIK 93751 · Bank · Dec 31, 2025
12,768
15
Tower Research Capital LLC (TRC)
13F CIK 1533421 · Unknown · Dec 31, 2025
3,230
16
UBS Group AG
13F CIK 1610520 · Bank · Dec 31, 2025
2,334
17
JPMORGAN CHASE & CO
13F CIK 19617 · Bank · Dec 31, 2025
2,253
18
BANK OF AMERICA CORP /DE/
13F CIK 70858 · Bank · Dec 31, 2025
382
19
FNY Investment Advisers, LLC
13F CIK 1742998 · Unknown · Dec 31, 2025
100
20
ROYAL BANK OF CANADA
13F CIK 1000275 · Bank · Dec 31, 2025
30

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1815974 CUSIP 034569103 Visit website Investor relations